Dana-Farber Cancer Institute, a principal teaching affiliate of Harvard Medical School, shares advances in cancer research and treatment with the healthcare community through continuing medical education (CME) courses.
Dana-Farber CME courses, offered in conjunction with Harvard Medical School or Partners HealthCare Office of Continuing Professional Development, which are both accredited by the Accreditation Council for Continuing Medical Education (ACCME), provide
continuing medical education for physicians. These educational activities have been designated as credit towards the AMA Physician's Recognition Award.
Cancer Survivorship: Optimizing Care and Outcomes
Available until April 26, 2024
Course and Registration Information
Master Class for Oncologists Series
Live, In-person course and Livestream
October 21-22, 2022
Virtual Tumor Board Session – Hematologic Malignancies
November 10, 2022
Virtual Tumor Board Session – Women’s Cancers
November 12, 2022
Registration and series information
Dana-Farber is a teaching affiliate of Harvard Medical School and founder of Dana-Farber/Harvard Cancer Center, a Comprehensive Cancer Center designated by the National Cancer Institute.
Visit our calendar of on-site educational opportunities for healthcare professionals, researchers and scientists, available through Dana-Farber and partnering institutions.